The Top Line
Duración total:
13 h 30 min
Untangling Sarepta’s gene therapy fallout and a growing trust deficit
The Top Line
27:07
Making sense of China’s R&D ascent
The Top Line
36:29
AI, mentorship and finding your voice in pharma marketing
The Top Line
13:15
Biopharma layoffs aren't letting up
The Top Line
10:24
Peter Pitts talks FDA direction, industry communication (Sponsored)
The Top Line
24:18
Teva’s CEO shares ‘Pivot to Growth’ progress
The Top Line
25:27
AbbVie, ADCs and the future of cancer care
The Top Line
17:32
Inside Fierce Medtech's Fierce 15
The Top Line
17:00
Inside ASCO 2025: Big data drops and a towering campaign
The Top Line
11:36
Forging the future of cell therapy: Bayer and BlueRock’s unique journey (Sponsored)
The Top Line
34:54
Science-led storytelling takes center stage in pharma communications (Sponsored)
The Top Line
17:55
Biopharma briefing: Q1 trends, gene therapy updates and ASCO preview
The Top Line
21:28
A Fierce breakdown of the 'most favored nation' executive order
The Top Line
15:20
Angela Hwang on her pivot from Big Pharma to biotech
The Top Line
29:41
ElevAAte and the push for East Asian American leaders in biopharma
The Top Line
35:59
Angus on Angus: A Fierce oncology discussion
The Top Line
36:58
Navigating Trump’s tariffs for pharma
The Top Line
25:12
Q1 biopharma layoff trends, plus expectations for Q2
The Top Line
11:29
A closer look at pharma's top R&D budgets
The Top Line
11:06
What diversity means in medtech
The Top Line
18:17
5 Key Questions About Precision Patient Marketing—Answered (Sponsored)
The Top Line
16:16
A closer look at pharma’s top patent losses in 2025
The Top Line
13:58
Agenus CMO touts immunotherapy advances on The Top Line
The Top Line
07:49
Breaking down pharma’s fourth-quarter sales boom
The Top Line
18:36
Inside the Future of Aseptic Manufacturing with GRAM (Sponsored)
The Top Line
22:25
Bridging the gap from clinical trials to real-life HIV care (Sponsored)
The Top Line
16:26
A look at biotech's biggest money raisers of 2024
The Top Line
09:34
Research reveals ‘ticking DNA clock’ behind Huntington’s disease
The Top Line
19:28
What were the biggest clinical trial flops of 2024?
The Top Line
10:17
A heartwarming roundup of cardiovascular news and most-loved stories
The Top Line
12:05
Looking ahead at the most anticipated drug launches of 2025
The Top Line
14:07
What to expect from the biotech IPO market in 2025
The Top Line
34:06
Recapping the 2025 J.P. Morgan Healthcare Conference
The Top Line
20:47
Fierce's forecasts for the next year in biopharma
The Top Line
25:10
An additional treatment option with TAGRISSO® (osimertinib) (Sponsored)
The Top Line
14:25
Breaking down the 55 new drug approvals of 2024
The Top Line
13:03
Fierce 50 honorees look ahead: AI, rural health, antibiotic resistance, maternal care and more
The Top Line
39:41
Novo Nordisk’s chief scientific officer looks to the future of GLP-1s
The Top Line
32:45
What can we learn from 2024’s biotech IPOs?
The Top Line
15:06
Meet 2024’s fiercest women in life sciences
The Top Line
12:30
